Skip to main content
Fig. 5 | Genome Medicine

Fig. 5

From: Cancer network activity associated with therapeutic response and synergism

Fig. 5

Assessment of the effect of drug pairs based on CNA evidence. a Left panel, heatmap showing the DCIs obtained by assessing metformin combinations with non-correlated (in the original dataset [8]) drugs in four breast cancer cell lines. Right panel, graph showing the results for metformin and/or olaparib in HCC-1954 cells. b Graph showing the results for metformin and/or olaparib in MCF10A cells. c Heatmap showing the DCIs obtained by assessing AZD-8055 combinations with correlated drugs

Back to article page